(Q40230301)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Manuel Sanchez-Martin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alfonso Gutiérrez-Adán

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Belen Pintado

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Isidro Sanchez-garcia

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Pérez-Caro M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gutierrez-Cianca N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

González-Herrero I

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

López-Hernández I

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Flores T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Orfao A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

18 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1702-1713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Timeline: Chemotherapy and the war on cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

STI571: targeting BCR-ABL as therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

The role of the tyrosine kinase inhibitor STI571 in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

SLUG in cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Cancer development induced by graded expression of Snail in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Consequences of chromosomal abnormalities in tumor development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Imatinib mesylate--a new oral targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Models of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Loss of p53 impedes the antileukemic response to BCR-ABL inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Chromosomal abnormalities and tumor development: from genes to therapeutic mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Characterization of acute lymphoblastic leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Immunoglobulin gene organisation and expression in haemopoietic stem cell leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Distribution of Philadelphia positive acute lymphoblastic leukemia: geographical heterogeneity or age related incidence?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209968

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16983340%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 December 2019

1014022322

0 references

1 reference